arrow
S

Sara T. Wester

Bascom Palmer Eye Institute
H指数:18
被引数:1,727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Efficacy and Safety of Teprotumumab in Geriatrics Patients: A Multicenter Study

:

2026-01-011
PRE
Teprotumumab-Related Adverse Events in Thyroid Eye Disease A Multicenter Study

Teprotumumab在甲状腺眼病中的相关不良事件多中心研究

2024-04-017
PRE
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity

Teprotumumab治疗病程长且疾病活动度低的甲状腺眼病患者的疗效和安全性

2023-10-3121
OA
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
2023-06-3021
OA
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

Teprotumumab在长期甲状腺眼病和再治疗中的疗效,安全性和持久性

2022-04-0184
OA
Teprotumumab for the Treatment of Active Thyroid Eye Disease

Teprotumumab用于治疗活动性甲状腺眼病

2020-01-23418
OAAI